Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
This Under-the-Radar Stock Is a Better Way to Bet on Coronavirus Vaccines
10:15am, Wednesday, 01'st Jul 2020
Emergent BioSolutions has become the go-to manufacturing partner for companies looking to develop vaccines for the coronavirus.
Race for a COVID-19 vaccine has drug makers scaling up manufacturing — before one is developed
06:06pm, Monday, 29'th Jun 2020
Inovio Pharmaceuticals Inc. has yet to share results from the Phase 1 trial for its COVID-19 vaccine candidate, but has already received millions of dollars in funding to scale up manufacturing capaci
3 Reasons Why Emergent Biosolutions (EBS) Is a Great Growth Stock
04:45pm, Monday, 29'th Jun 2020
Emergent Biosolutions (EBS) could produce exceptional returns because of its solid growth attributes.
Why Vaxart Shares Are Vaulting Higher Again | The Motley Fool
04:33pm, Monday, 29'th Jun 2020
Momentum from last week's big news continues.
Ascendis Submits BLA to FDA for TransConhGH in Pediatric GHD
03:44pm, Monday, 29'th Jun 2020
Ascendis Pharma (ASND) submits BLA to the FDA for TransConhGH for the treatment of pediatric growth hormone deficiency.
Vertex's Triple Combo Cystic Fibrosis Pill Gets CHMP Backing
01:12pm, Monday, 29'th Jun 2020
Vertex (VRTX) is seeking approval in Europe for its triple combo pill, Kaftrio in combination with Kalydeco to treat cystic fibrosis in patients aged 12 and older with most common genotypes.
Guggenheim Capital LLC Has $7.46 Million Stock Holdings in Emergent Biosolutions Inc (NYSE:EBS)
08:06am, Sunday, 28'th Jun 2020
Guggenheim Capital LLC decreased its stake in Emergent Biosolutions Inc (NYSE:EBS) by 0.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange C
Vaxart says potential COVID-19 vaccine picked for 'Operation Warp Speed'
04:05pm, Friday, 26'th Jun 2020
Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the Trump administration's vaccine-acceleration program
iBio Is in a Healthy Position With Covid-19 Vaccine Push
03:48pm, Friday, 26'th Jun 2020
The novel coronavirus pandemic has swept away several industries but has been a bit of a blessing for the biotech sector. iBio (NYSEMKT:IBIO) is one company that is benefiting from the hype surroundin
Vaxart says potential Covid-19 vaccine picked for 'Operation Warp Speed'
03:25pm, Friday, 26'th Jun 2020
BENGALURU (June 26): Vaxart Inc said on Friday it would test its experimental oral Covid-19 vaccine on monkeys infected with the new coronavirus in a study funded by the Trump administration's vaccine
Vaxart says potential COVID-19 vaccine picked for 'Operation Warp Speed'
01:56pm, Friday, 26'th Jun 2020
Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the Trump administration's vaccine-acceleration program
If a coronavirus vaccine is developed, what will be the next challenges?
06:03am, Friday, 26'th Jun 2020
Covid vaccine makers face biggest medical manufacturing challenge in history.Companies and governments are racing to scale-up machinery to address a critical shortage in automated filling and finishin
